TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 83 filers reported holding TANGO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,615,596 | +52.7% | 143,481 | -55.0% | 0.01% | +66.7% |
Q2 2023 | $1,058,336 | -33.9% | 318,776 | -21.4% | 0.01% | -40.0% |
Q1 2023 | $1,601,982 | -36.2% | 405,565 | +17.1% | 0.01% | -41.2% |
Q4 2022 | $2,511,915 | +100.6% | 346,471 | +0.2% | 0.02% | +70.0% |
Q3 2022 | $1,252,000 | – | 345,923 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |